Education
About Us
Working with TipRanks
Follow Us
Panacea Life Sciences Holdings Inc (PLSH)
:PLSH
PLSH Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.03 - $0.19
Previous CloseN/A
Volume1.00K
Average Volume (3M)4.28K
Market Cap
$741.56K
Enterprise ValueN/A
Total Cash (Recent Filing)$1.06M
Total Debt (Recent Filing)$0.00
Price to Earnings (P/E)―
Beta1.40
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.06
Shares Outstanding20,261,288
10 Day Avg. Volume2,568
30 Day Avg. Volume4,283
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.37
Price to Cash Flow (P/CF)-0.70
P/FCF Ratio3.80
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Panacea Life Sciences Holdings Inc News
PremiumCompany Announcements
Panacea Life Sciences Strikes, Rescinds PUR Medical Deal---
Ownership Overview
―
Insiders
―
Mutual Funds
<0.01% Other Institutional Investors
100.00% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
PLSH FAQ
What was Panacea Life Sciences Holdings Inc’s price range in the past 12 months?
Panacea Life Sciences Holdings Inc lowest stock price was $0.03 and its highest was $0.19 in the past 12 months.
What is Panacea Life Sciences Holdings Inc’s market cap?
Panacea Life Sciences Holdings Inc’s market cap is $741.56K.
When is Panacea Life Sciences Holdings Inc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Panacea Life Sciences Holdings Inc’s earnings last quarter?
Panacea Life Sciences Holdings Inc released its earnings results on Nov 19, 2020. The company reported -$1.01 earnings per share for the quarter, missing the consensus estimate of N/A by -$1.01.
Is Panacea Life Sciences Holdings Inc overvalued?
According to Wall Street analysts Panacea Life Sciences Holdings Inc’s price is currently Overvalued.
Does Panacea Life Sciences Holdings Inc pay dividends?
Panacea Life Sciences Holdings Inc does not currently pay dividends.
What is Panacea Life Sciences Holdings Inc’s EPS estimate?
Panacea Life Sciences Holdings Inc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Panacea Life Sciences Holdings Inc have?
Panacea Life Sciences Holdings Inc has 20,261,288 shares outstanding.
What happened to Panacea Life Sciences Holdings Inc’s price movement after its last earnings report?
Panacea Life Sciences Holdings Inc reported an EPS of -$1.01 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of Panacea Life Sciences Holdings Inc?
Currently, no hedge funds are holding shares in PLSH
---
Company Description
Panacea Life Sciences Holdings Inc
Panacea Life Sciences Holdings, Inc., a seed to sale cannabinoid and nutraceutical manufacturer and research company, develops and produces natural pharmaceutical alternatives for consumers and pets. The company manufactures and sells softgels, gummies, tinctures, sublingual tablets, cosmetics, and other topicals. It is also involved in the personal protection equipment (PPE) business, including importing and selling PPE hand sanitizers and masks, as well as white label and contract manufacturing sales to other cannabinoid companies, raw material sales, and tolling arrangements. The company was incorporated in 2008 and is headquartered in Greenwood Village, Colorado.
---
Technical Analysis
---